SEVENTEEN YEARS EXPERIENCE OF EBRT PLUS HDR BRACHYTHERAPY BOOST IN HIGH-RISK LOCALIZED PROSTATE CANCER PATIENTS: A COMPETING RISKS ANALYSIS

被引：0
|
作者：
Carignan, Damien [1 ]
Despres, Philippe [1 ]
Magnan, Sindy [2 ]
Froment, Marie-Anne [2 ]
Foster, William [2 ]
Aubin, Sylviane [2 ]
Lavallee, Marie-Claude [2 ]
Lacroix, Frederic [2 ]
Cantin, Audrey [2 ]
Poulin, Eric [2 ]
Martin, Andre-Guy [2 ]
Vigneault, Eric [2 ]
机构：
[1] Univ Laval, Quebec City, PQ, Canada
[2] Univ Laval, CHU Quebec, Quebec City, PQ, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 150卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14
引用
收藏
页码：S9 / 510
页数：2
相关论文
共 50 条
  • [31] Reconsidering the case for brachytherapy plus EBRT in high-risk prostate cancer - The Bittner/Merrick/Wallner et al article reviewed
    Kuban, Deborah A.
    [J]. ONCOLOGY-NEW YORK, 2008, 22 (09): : 1006 - +
  • [32] HDR brachytherapy as a boost for intermediate and high risk prostate cancer: Longterm outcome of 2028 implants
    Kurek, R
    Martin, T
    Buhleier, T
    Dannenberg, T
    Baltas, D
    Zamboglou, N
    Tunn, UW
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 314 - 314
  • [33] HDR Brachytherapy boost irradiation in the radiotherapy (RT) of intermediate and high risk localised prostate cancer
    Agoston, P
    Major, T
    Somogyi, A
    Baricza, K
    Szasz, K
    Lövey, J
    Németh, G
    Kasler, M
    Fodor, J
    [J]. RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S4 - S5
  • [34] A Matched Comparison of High-Risk Prostate Cancer Patients Treated With Dose-Escalated, Image Guided Adaptive External Beam Radiation Therapy (EBRT) Versus Pelvic EBRT Plus High-Dose-Rate Brachytherapy Boost
    Blas, K. G.
    Brown, M. E.
    Wallace, M.
    Tonlaar, N. Y.
    Stone, B. M.
    Chen, P. Y.
    Gustafson, G. S.
    Brabbins, D. S.
    Yan, D.
    Ye, H.
    Krauss, D. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S121 - S122
  • [35] LONG-TERM RESULTS OF HIGH-DOSE EBRT AND EBRT WITH BRACHYTHERAPY BOOST IN TREATMENT OF PROSTATE CANCER PATIENTS.
    Smolska-Ciszewska, B.
    Miszczyk, L.
    Bialas, B.
    Gawkowska-Suwinska, M.
    Plewicki, G.
    Fijalkowski, M.
    Giglok, M.
    Behrendt, K.
    Nowicka, E.
    Zajusz, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S286 - S286
  • [36] Conformal radiotherapy plus high dose rate brachytherapy prostate boost in patients with intermediate and high risk prostate cancer: our experience in Asian males
    Tunio, Mutahir A.
    Hashmi, Altaf
    Sattar, Amjad
    Mohsin, Rehan
    Ali, Shoukat
    Maqbool, Amir
    [J]. JOURNAL OF RADIOTHERAPY IN PRACTICE, 2012, 11 (04) : 257 - 270
  • [37] 10-year results in 1577 intermediate/high risk prostate cancer patients treated with external beam RT (EBRT) and hypofractionated high dose rate (HDR) brachytherapy boost
    Ghilezan, M.
    Galalae, R.
    Demanes, J.
    Schour, L.
    Gustafson, G.
    Nuemberg, N.
    Wallace, M.
    Martinez, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S83 - S84
  • [38] Improved survival for patients with prostate cancer receiving high-dose-rate brachytherapy boost to EBRT compared with EBRT alone
    Kent, Aaron R.
    Matheson, Bronwyn
    Millar, Jeremy L.
    [J]. BRACHYTHERAPY, 2019, 18 (03) : 313 - 321
  • [39] The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer
    Thiruthaneeswaran, N.
    Bibby, B. A. S.
    Pereira, R.
    More, E.
    Denley, H.
    Henry, A.
    Wylie, J.
    Hoskin, P.
    Bristow, R.
    Choudhury, A.
    West, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S1086 - S1087
  • [40] Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with brachytherapy boost
    Shortall, Jane
    Osorio, Eliana Vasquez
    Green, Andrew
    McWilliam, Alan
    Elumalai, Thriaviyam
    Reeves, Kimberley
    Johnson-Hart, Corinne
    Beasley, William
    Hoskin, Peter
    Choudhury, Ananya
    van Herk, Marcel
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
12345